A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
The 2016 ASCO guidelines focused primarily on disease burden and surgical resectability, whereas the 2024 National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for ovarian ...
Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...
The NCCN finalized these updates before data ... is covered by Medicare for patients with colorectal cancer, breast cancer, ovarian cancer, and muscle-invasive bladder cancer, as well as for ...
Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has released a new resource aimed at helping individuals understand genetic testing and counseling for hereditary cancers.
Part of the decision-making process may include considerations from the National Comprehensive Cancer Network (NCCN), which provides expert-developed guidelines that doctors use to determine the best ...
"The NCCN Guidelines are widely recognized as a key indicator of standards of excellence for cancer care and prevention. We believe the current alignment between these highly influential cancer ...
Leading oncology experts explain the reasons for joining a cancer clinical trial and provide information on how to make it happen. Visit NCCN.org/patientwebinars to ...